Concurrent Investment Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.33M Buy
12,866
+59
+0.5% +$6.69K 0.01% 763
2025
Q4
$1.29M Sell
12,807
-6,664
-34% -$723K 0.01% 725
2025
Q3
$2.4M Sell
19,471
-637
-3% -$79.1K 0.04% 419
2025
Q2
$2.41M Buy
20,108
+232
+1% +$31K 0.05% 385
2025
Q1
$2.93M Buy
19,876
+4,589
+30% +$701K 0.07% 289
2024
Q4
$2.48M Sell
15,287
-797
-5% -$130K 0.07% 280
2024
Q3
$2.62M Buy
16,084
+760
+5% +$113K 0.08% 245
2024
Q2
$2.09M Buy
15,324
+5,358
+54% +$744K 0.07% 267
2024
Q1
$1.53M Sell
9,966
-1,120
-10% -$167K 0.06% 291
2023
Q4
$1.58M Buy
+11,086
New +$1.48M 0.07% 262

Other funds holding CLX

Concurrent Investment Advisors's CLX Position: Q1 2026 in Review

Concurrent Investment Advisors increased its Clorox (CLX) stake by 0.46% in Q1 2026, buying an estimated $6.69K and bringing the position to 12,866 shares worth $1.33M. The position accounts for 0.01% of the portfolio, ranked #763.

Concurrent Investment Advisors first reported a position in CLX in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.93M in Q1 2025. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Concurrent Investment Advisors held 12,866 shares of Clorox worth $1.33M as of Q1 2026.
  • Concurrent Investment Advisors bought 59 Clorox shares in Q1 2026, an estimated $6.69K.
  • Clorox made up 0.01% of Concurrent Investment Advisors's portfolio in Q1 2026, its #763 holding.
  • Concurrent Investment Advisors first reported a position in Clorox in Q4 2023 and has held it in 10 quarters since.
  • Concurrent Investment Advisors's Clorox position peaked at $2.93M in Q1 2025.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.